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                IV Push Administration of Drugsa 
 
This list is intended to be used as a guide when use of IV administration pumps or number of direct contacts with an infectious patient needs to be minimized. It is not an exhaustive list. 
 
Antimicrobials 
Drug Dose Diluent Diluent Volume Administration Rate 
Ampicillin 125 mg, 250 mg,  
500 mg 
SWI, BWI 5 mL 3 – 5 minutes 
 1 g SWI, BWI 7.4 mL 10 – 15 minutes 
 2 g SWI, BWI 14.8 mL 10 – 15 minutes 
Aztreonam 1 g, 2 g SWI 6 – 10 mL 3 – 5 minutes 
Cefazolin1,2,3 1 g, 2g SWI 10 mL 3 – 5 minutes 
Cefepime1,4 1 g SWI, NS 10 mL  2 – 5 minutes 
 2 g SWI, NS 20 mL (SWI), 10 mL (NS) 2 – 5 minutes 
Cefotaxime 1 g, 2 g SWI 10 mL 3 – 5 minutes 
Cefotetan 1 g, 2g SWI 10 mL 3 – 5 minutes 
Cefoxitin 1 g, 2g  SWI, BWI, NS, D5W 10 mL 3 – 5 minutes 
Ceftazidime 1 g, 2 g SWI 10 mL 3 – 5 minutes 
Ceftriaxone1,2,3 1 g, 2 g SWI 10 mL 1 – 4 minutes 
Cefuroxime 750 mg SWI 8.3 mL 3 – 5 minutes 
 1.5 g SWI 16 mL 3 – 5 minutes 
Colistimethate  Na  150 mg SWI 2 mL 3 – 5 minutes 
Daptomycin 350 mg NS 7 mL 2 minutes 
 500 mg NS 10 mL 2 minutes 
Daptomycin RF 500 mg SWI, BWI 10 mL 2 minutes 
Gentamicin5 Up to 800 mg NS 20 mL total volume 3 – 5 minutes 
 800 mg or more Not required Not required 3 – 5 minutes 
Meropenem 500 mg SWI 10 mL 3 – 5 minutes 
 1 g  SWI 20 mL 3 – 5 minutes 
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This list is intended to be used as a guide when use of IV administration pumps or number of direct contacts with an infectious patient needs to be minimized. It is not an exhaustive list. 
 
  Antimicrobials  
Drug Dose Diluent Diluent Volume Administration Rate 
Oxacillin 1 g SWI, NS 10 mL 10 minutes 
 2 g SWI, NS 20 mL 10 minutes 
Tobramycin5 Up to 800 mg NS 20 mL total volume 3 – 5 minutes 
 800 mg or more Not required Not required 3 – 5 minutes 
Analgesics 
Drug Dose Diluent Diluent Volume Administration Rate 
Fentanyl 50 – 100 mcg Not required Not required 1 – 3 minutes 
Hydromorphone 0.5 – 1 mg Not required Not required 2 – 3 minutes 
Ketorolac 15 – 30 mg Not required Not required Over at least 15 seconds 
Anticonvulsants 
Drug Dose Diluent Diluent Volume Administration Rate 
Fosphenytoin Various NS, D5W Max Conc: 25 mg PE/mL Max:150 mg PE/minute 
Lacosamide6,7,8 Up to Max: 400 mg Not required Not required 40 – 80 mg/minute 
Pentobarbital Various Not required Not required Max: 50 mg/minute 
Phenobarbitalb Various Not required Not required Max: 60 mg/minute 
Phenytoin Various Not required Not required Max: 50 mg/minute 
Benzodiazepines 
Drug Dose Diluent Diluent Volume Administration Rate 
Diazepam 5 mg Not required Not required Over at least 1 minute 
Lorazepam 2 – 4 mg SWI, NS, D5W Equal volume of dose volume Max: 2 mg/minute 
Midazolam 1 – 2.5 mg Not required Not required Over at least 2 minutes 
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This list is intended to be used as a guide when use of IV administration pumps or number of direct contacts with an infectious patient needs to be minimized. It is not an exhaustive list. 
 
Corticosteroids 
Drug Dose Diluent Diluent Volume Administration Rate 
Dexamethasone Various Not required Not required Over at least 1 minute 
Hydrocortisone 100 – 500 mg BWI Up to 2 mL Max: 30 seconds per 100 mg 
Methylprednisolone Up to Max: 250 mg BWI with benzoyl 
alcohol 
2 mL 3 – 10 minutes 
Diuretics 
Drug Dose Diluent Diluent Volume Administration Rate 
Acetazolamide 500 mg SWI At least 5 mL  
Max Conc: 100mg/mL 
Max: 500 mg/minute 
Bumetanide 0.5 – 1 mg Not required Not required 1 – 2 minutes 
Ethacrynic Acid 50 mg D5W, NS 50 mL Several minutes 
Furosemide 20 – 40 mg Not Required Not Required 1 – 2 minutes 
Gastrointestinal Agents 
Drug Dose Diluent Diluent Volume Administration Rate 
Esomeprazole 20 mg, 40 mg NS 5 mL Over at least 3 minutes 
Famotidine 20 mg NS 5 – 10 mL Over at least 2 minutes 
Granisetron 10 mcg/kg Not required Not required 30 seconds 
Metoclopramide Up to 10 mg Not required Not required 1 – 2 minutes 
Ondansetron Up to 4 mg Not required Not required 30 seconds – 5 minutes 
Pantoprazole 40 mg NS 10 mL Over at least 2 minutes 
Prochlorperazine 5 – 10 mg Not required Not required Max: 5 mg/minute 
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Miscellaneous Agents 
Drug Dose Diluent  Diluent Volume Administration 
Rate 
Diphenhydramine 25 – 50 mg Not required Not required Max: 25 mg/minute 
Etomidate 0.2 – 0.6 mg/kg Not required Not required 30 – 60 sec 
Ketamine 1 – 4.5 mg/kg SWI, NS, D5W Equal volume of dose volume  
(Max Conc = 50 mg/mL) 
Over at least 1 minute 
Propofol 10 – 20 mg Not required Not required 3 – 5 minutes 
Naloxone 0.4 – 2 mg Not required Not required 60 seconds or less 
Levothyroxine 100 – 200 mcg NS 5 mL Max: 100 mcg/minute 
Octreotide 50 mcg Not required Not required 3 minutes 
Neuromuscular Blockersc 
Drug Dose Diluent Diluent Volume Administration 
Rate 
Atracurium9 0.4 – 0.5 mg/kg Not required Not required 60 seconds or less 
Cisatracurium9 0.1 – 0.2 mg/kg Not required Not required 60 seconds or less 
Mivacurium9 0.15 – 0.25 mg/kg Not required Not required 5 – 30 seconds 
Pancuronium9 0.06 – 0.1 mg/kg Not required Not required 60 seconds or less 
Rocuronium9 0.6 – 1 mg/kg Not required Not required 60 seconds or less 
Succinylcholine 0.3 – 1.1 mg/kg Not required Not required 10 – 30 seconds 
Vecuronium9 0.08 – 0.1 mg/kg BWI 10 mL for 10 mg vial 
20 mL for 20 mg vial 
60 seconds or less 
Abbreviations: NS – 0.9% Sodium Chloride Injection; D5W – 5% Dextrose Injection; BWI – Bacteriostatic Water for Injection; SWI – Sterile Water for Injection. 
a Information is from the package insert unless otherwise specified. 
bA rate of 75 – 100 mg/min can be used in emergency situations; hypotension and ventilation may be necessary at these rates 
cInitial or loading dose; other doses may be used but depend on indication and patient-specific factors. 
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